These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4201030)

  • 1. Drug additive compatibility--a manufacturer's concern.
    Nedich RL
    Bull Parenter Drug Assoc; 1973; 27(5):228-33. PubMed ID: 4201030
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations to pharmacists for solving problems with large-volume parenterals.
    Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199
    [No Abstract]   [Full Text] [Related]  

  • 3. Parenteral incompatibilities--past, present and future.
    Parker EA; Boomer RJ; Bell SC
    Bull Parenter Drug Assoc; 1967; 21(6):197-207. PubMed ID: 6078886
    [No Abstract]   [Full Text] [Related]  

  • 4. Mixing drugs with intravenous infusions.
    Drug Ther Bull; 1970 Jul; 8(14):53-6. PubMed ID: 5451629
    [No Abstract]   [Full Text] [Related]  

  • 5. Compatibility guide for combining IV medications.
    Ng PK
    Am J Nurs; 1979 Jul; 79(7):1292-5. PubMed ID: 256451
    [No Abstract]   [Full Text] [Related]  

  • 6. Solution additive chemical incompatibility study.
    Parker EA
    Am J Hosp Pharm; 1967 Aug; 24(8):434-9. PubMed ID: 6075728
    [No Abstract]   [Full Text] [Related]  

  • 7. I.V. additives move to the pharmacy.
    Peritore SP; Rosenberg JM
    Hospitals; 1971 Dec; 45(24):84-91. PubMed ID: 5135288
    [No Abstract]   [Full Text] [Related]  

  • 8. A guide to admixture compatibility. Part 3.
    RN; 1973 Dec; 36(12):32-7. PubMed ID: 4490643
    [No Abstract]   [Full Text] [Related]  

  • 9. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.
    Allen LV; Levinson RS; Phisutsinthop D
    Am J Hosp Pharm; 1977 Sep; 34(9):939-43. PubMed ID: 20779
    [No Abstract]   [Full Text] [Related]  

  • 10. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2.
    Allen LV; Stiles ML
    Am J Hosp Pharm; 1981 Mar; 38(3):380-1. PubMed ID: 7223755
    [No Abstract]   [Full Text] [Related]  

  • 11. IV additive service.
    McLemore RA
    Hospitals; 1971 Mar; 45(6):96-8. PubMed ID: 5547690
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual compatibility of ganciclovir sodium and total parenteral nutrient solution during simulated Y-site injection.
    Outman WR; Mitrano FP; Baptista RJ
    Am J Hosp Pharm; 1991 Jul; 48(7):1538-9. PubMed ID: 1909095
    [No Abstract]   [Full Text] [Related]  

  • 13. The compatibility and stability of midazolam and dexamethasone in infusion solutions.
    Good PD; Schneider JJ; Ravenscroft PJ
    J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of amphotericin B with drugs used to reduce adverse reactions.
    Gotz VP; Mar DD; Roche JJ
    Am J Hosp Pharm; 1981 Mar; 38(3):378-9. PubMed ID: 7223754
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the stability and compatibility of drugs in infusion fluids. VI. Factors affecting the stability of ampicillin.
    Stjernström G; Olson OT; Nyqvist H; Lundgren P
    Acta Pharm Suec; 1978; 15(1):33-50. PubMed ID: 25558
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous versus intermittent intravenous antibiotics.
    Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663
    [No Abstract]   [Full Text] [Related]  

  • 17. Compatibility and stability of clindamycin phosphate with intravenous fluids.
    Porter WR; Johnson CA; Cohon MS; Gillespie W
    Am J Hosp Pharm; 1983 Jan; 40(1):91-4. PubMed ID: 6823996
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous admixture incompatibility.
    Donn R
    Am J Nurs; 1971 Feb; 71(2):325. PubMed ID: 5203610
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug incompatibility from the standpoint of the intravenous route of drug administration.
    Williams JT
    Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting pharmaceutical incompatibilities of parenteral medications.
    Carlin HS; Perkins AJ
    Am J Hosp Pharm; 1968 Jun; 25(6):270-9. PubMed ID: 5656772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.